tiprankstipranks
Advertisement
Advertisement

Epigral Board Clears Q3 and Nine-Month FY25 Unaudited Results

Story Highlights
Epigral Board Clears Q3 and Nine-Month FY25 Unaudited Results

Claim 55% Off TipRanks

Epigral Ltd ( (IN:EPIGRAL) ) has provided an announcement.

Epigral Limited reported that its board of directors met on January 30, 2026, at the company’s registered office in Ahmedabad. At this meeting, the board approved the company’s unaudited standalone and consolidated financial results for the third quarter and nine months ended December 31, 2025, and noted the accompanying limited review report from its statutory auditors. The disclosure fulfills the company’s regulatory obligations to the stock exchanges and signals that interim financial performance figures for the period are now formally on record for investors and other stakeholders.

More about Epigral Ltd

Average Trading Volume: 2,927

Technical Sentiment Signal: Sell

Current Market Cap: 45.11B INR

Find detailed analytics on EPIGRAL stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1